MGNX Insider Trading

Insider Ownership Percentage: 11.30%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $1,626,689.93

MacroGenics Insider Trading History Chart

This chart shows the insider buying and selling history at MacroGenics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

MacroGenics Share Price & Price History

Current Price: $3.19
Price Change: Price Decrease of -0.09 (-2.74%)
As of 11/21/2024 01:00 AM ET

This chart shows the closing price history over time for MGNX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

MacroGenics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/4/2024Jeffrey Stuart PetersVPSell51,395$15.55$799,192.25View SEC Filing Icon  
2/26/2024Jeffrey Stuart PetersVPSell16,124$17.22$277,655.288,895View SEC Filing Icon  
2/1/2024Ezio BonviniSVPSell13,316$15.00$199,740.0074,668View SEC Filing Icon  
1/19/2024Ezio BonviniSVPSell13,316$12.00$159,792.0087,984View SEC Filing Icon  
12/20/2023Ezio BonviniSVPSell18,880$10.08$190,310.40101,300View SEC Filing Icon  
10/2/2023Target N V BiotechMajor ShareholderBuy150,000$4.46$669,000.009,929,963View SEC Filing Icon  
9/7/2023Target N V BiotechMajor ShareholderBuy200,000$5.26$1,052,000.009,779,963View SEC Filing Icon  
8/30/2023Edward HurwitzDirectorBuy15,000$4.91$73,650.0033,074View SEC Filing Icon  
3/10/2023Jeffrey Stuart PetersVPSell5,372$6.03$32,393.16View SEC Filing Icon  
2/14/2023Target N V BiotechMajor ShareholderBuy500,000$5.07$2,535,000.009,579,963View SEC Filing Icon  
1/19/2023Target N V BiotechMajor ShareholderBuy150,000$5.30$795,000.009,079,963View SEC Filing Icon  
12/27/2022Target N V BiotechMajor ShareholderBuy200,000$5.61$1,122,000.008,929,963View SEC Filing Icon  
12/23/2022Target N V BiotechMajor ShareholderBuy200,000$5.88$1,176,000.008,729,963View SEC Filing Icon  
11/22/2022Target N V BiotechMajor ShareholderBuy300,000$5.96$1,788,000.008,529,963View SEC Filing Icon  
10/24/2022Target N V BiotechMajor ShareholderBuy250,000$4.36$1,090,000.008,229,963View SEC Filing Icon  
10/21/2022Target N V BiotechMajor ShareholderBuy250,000$4.63$1,157,500.007,979,963View SEC Filing Icon  
10/19/2022Target N V BiotechMajor ShareholderBuy168,422$3.70$623,161.407,443,986View SEC Filing Icon  
6/15/2022James KarrelsCFOBuy40,000$2.47$98,800.00191,776View SEC Filing Icon  
11/19/2021Target N V BiotechMajor ShareholderBuy200,000$18.50$3,700,000.00View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for MacroGenics (NASDAQ:MGNX)

96.89% of MacroGenics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at MGNX by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

MacroGenics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/19/2024Barclays PLC98,753$0.33M0.0%+97.1%0.157%Search for SEC Filing on Google Icon
11/16/2024Geode Capital Management LLC1,406,876$4.63M0.0%-0.6%2.242%Search for SEC Filing on Google Icon
11/15/2024Barclays PLC98,753$0.33M0.0%+97.1%0.157%Search for SEC Filing on Google Icon
11/15/2024XTX Topco Ltd11,178$37K0.0%N/A0.018%Search for SEC Filing on Google Icon
11/15/2024Wellington Management Group LLP307,140$1.01M0.0%+15.7%0.489%Search for SEC Filing on Google Icon
11/15/2024State Street Corp1,427,390$4.70M0.0%-7.5%2.274%Search for SEC Filing on Google Icon
11/15/2024Stifel Financial Corp39,888$0.13M0.0%+19.7%0.064%Search for SEC Filing on Google Icon
11/15/2024Ikarian Capital LLC80,079$0.26M0.0%-60.0%0.128%Search for SEC Filing on Google Icon
11/15/2024Jacobs Levy Equity Management Inc.566,328$1.86M0.0%+35.2%0.902%Search for SEC Filing on Google Icon
11/14/2024Bellevue Group AG9,929,963$32.67M0.5%-0.1%15.822%Search for SEC Filing on Google Icon
11/14/2024Wasatch Advisors LP2,535,802$8.34M0.0%+3.4%4.040%Search for SEC Filing on Google Icon
11/14/2024PDT Partners LLC160,039$0.53M0.0%+44.5%0.255%Search for SEC Filing on Google Icon
11/14/2024Verition Fund Management LLC90,304$0.30M0.0%N/A0.144%Search for SEC Filing on Google Icon
11/14/2024Vestal Point Capital LP830,000$2.73M0.2%+3.8%1.322%Search for SEC Filing on Google Icon
11/14/2024Walleye Capital LLC114,744$0.38M0.0%-43.7%0.183%Search for SEC Filing on Google Icon
11/14/2024MetLife Investment Management LLC15,093$50K0.0%-57.5%0.024%Search for SEC Filing on Google Icon
11/13/2024BNP Paribas Financial Markets90,779$0.30M0.0%+374.4%0.145%Search for SEC Filing on Google Icon
11/13/2024FMR LLC137,215$0.45M0.0%+1,230.1%0.219%Search for SEC Filing on Google Icon
11/12/2024Charles Schwab Investment Management Inc.492,765$1.62M0.0%-3.5%0.785%Search for SEC Filing on Google Icon
11/9/2024Intech Investment Management LLC20,763$68K0.0%N/A0.033%Search for SEC Filing on Google Icon
11/8/2024Connor Clark & Lunn Investment Management Ltd.661,914$2.18M0.0%+39.3%1.055%Search for SEC Filing on Google Icon
11/5/2024GSA Capital Partners LLP207,877$0.68M0.1%+117.2%0.331%Search for SEC Filing on Google Icon
11/2/2024XML Financial LLC17,600$58K0.0%+66.0%0.028%Search for SEC Filing on Google Icon
10/25/2024Pinnacle Associates Ltd.687,980$2.26M0.0%+7.9%1.097%Search for SEC Filing on Google Icon
10/25/2024China Universal Asset Management Co. Ltd.12,064$40K0.0%+64.0%0.019%Search for SEC Filing on Google Icon
10/10/2024Exchange Traded Concepts LLC48,823$0.16M0.0%+260.8%0.078%Search for SEC Filing on Google Icon
10/3/2024SG Americas Securities LLC16,822$55K0.0%N/A0.027%Search for SEC Filing on Google Icon
8/16/2024Frazier Life Sciences Management L.P.3,010,727$12.80M0.6%+21.8%4.807%Search for SEC Filing on Google Icon
8/15/2024Susquehanna Fundamental Investments LLC129,996$0.55M0.0%+22.9%0.208%Search for SEC Filing on Google Icon
8/15/2024Millennium Management LLC3,312,672$14.08M0.0%+3,473.7%5.289%Search for SEC Filing on Google Icon
8/15/2024AQR Capital Management LLC143,161$0.61M0.0%+74.5%0.229%Search for SEC Filing on Google Icon
8/15/2024Armistice Capital LLC6,000,000$25.50M0.3%+150.0%9.580%Search for SEC Filing on Google Icon
8/14/2024K2 Principal Fund L.P.14,800$63K0.0%N/A0.024%Search for SEC Filing on Google Icon
8/14/2024Marshall Wace LLP658,007$2.80M0.0%+1,689.3%1.051%Search for SEC Filing on Google Icon
8/14/2024DRW Securities LLC13,105$56K0.0%N/A0.021%Search for SEC Filing on Google Icon
8/14/2024ProShare Advisors LLC12,018$51K0.0%-21.4%0.019%Search for SEC Filing on Google Icon
8/12/2024Hsbc Holdings PLC12,103$50K0.0%-27.7%0.019%Search for SEC Filing on Google Icon
8/9/2024Renaissance Technologies LLC484,027$2.06M0.0%-32.3%0.773%Search for SEC Filing on Google Icon
8/9/2024Dimensional Fund Advisors LP898,497$3.82M0.0%-14.5%1.435%Search for SEC Filing on Google Icon
8/8/2024Federated Hermes Inc.300,499$1.28M0.0%-33.8%0.480%Search for SEC Filing on Google Icon
8/6/2024Acadian Asset Management LLC586,079$2.49M0.0%+23.8%0.936%Search for SEC Filing on Google Icon
8/3/2024TD Asset Management Inc169,000$0.72M0.0%-20.8%0.270%Search for SEC Filing on Google Icon
8/1/2024Rhumbline Advisers88,294$0.38M0.0%-5.2%0.141%Search for SEC Filing on Google Icon
7/30/2024Pinnacle Associates Ltd.637,319$2.71M0.0%-1.5%1.018%Search for SEC Filing on Google Icon
7/29/2024Principal Financial Group Inc.348,421$1.48M0.0%+1.1%0.556%Search for SEC Filing on Google Icon
7/29/2024Panagora Asset Management Inc.741,490$3.15M0.0%+60.0%1.184%Search for SEC Filing on Google Icon
7/29/2024Zurcher Kantonalbank Zurich Cantonalbank16,072$68K0.0%+300.6%0.026%Search for SEC Filing on Google Icon
7/26/2024Bank of New York Mellon Corp261,944$1.11M0.0%+4.9%0.418%Search for SEC Filing on Google Icon
7/16/2024Diversified Trust Co18,097$77K0.0%+32.8%0.029%Search for SEC Filing on Google Icon
5/17/2024RA Capital Management L.P.2,082,021$30.65M0.4%-48.6%3.324%Search for SEC Filing on Google Icon
5/16/2024California State Teachers Retirement System47,955$0.71M0.0%+378.7%0.077%Search for SEC Filing on Google Icon
5/16/2024Jacobs Levy Equity Management Inc.148,018$2.18M0.0%+28.7%0.236%Search for SEC Filing on Google Icon
5/16/2024Janus Henderson Group PLC33,403$0.49M0.0%N/A0.053%Search for SEC Filing on Google Icon
5/15/2024Bellevue Group AG9,965,862$146.70M2.2%+0.1%15.912%Search for SEC Filing on Google Icon
5/15/2024Price T Rowe Associates Inc. MD2,438,050$35.89M0.0%+8,361.6%3.893%Search for SEC Filing on Google Icon
5/15/2024Avoro Capital Advisors LLC6,150,000$90.53M1.1%N/A9.820%Search for SEC Filing on Google Icon
5/14/2024EntryPoint Capital LLC2,695$40K0.0%N/A0.004%Search for SEC Filing on Google Icon
5/14/2024CANADA LIFE ASSURANCE Co3,508$52K0.0%N/A0.006%Search for SEC Filing on Google Icon
5/10/2024Acadian Asset Management LLC473,413$6.97M0.0%-55.2%0.757%Search for SEC Filing on Google Icon
5/10/2024Vanguard Group Inc.3,677,678$54.14M0.0%-14.7%5.879%Search for SEC Filing on Google Icon
5/8/2024ProShare Advisors LLC15,282$0.23M0.0%+8.9%0.024%Search for SEC Filing on Google Icon
5/7/2024Susquehanna Fundamental Investments LLC105,787$1.56M0.1%+597.4%0.169%Search for SEC Filing on Google Icon
5/7/2024Susquehanna Portfolio Strategies LLC58,624$0.86M0.0%-60.7%0.094%Search for SEC Filing on Google Icon
5/7/2024Swiss National Bank91,800$1.35M0.0%N/A0.147%Search for SEC Filing on Google Icon
5/7/2024ClariVest Asset Management LLC117,919$1.74M0.2%-36.9%0.188%Search for SEC Filing on Google Icon
5/1/2024BNP Paribas Financial Markets35,313$0.52M0.0%-16.1%0.056%Search for SEC Filing on Google Icon
5/1/2024Mirae Asset Global Investments Co. Ltd.57,060$0.84M0.0%+15.7%0.091%Search for SEC Filing on Google Icon
4/30/2024Allspring Global Investments Holdings LLC12,701$0.19M0.0%-68.9%0.020%Search for SEC Filing on Google Icon
4/29/2024Principal Financial Group Inc.344,603$5.07M0.0%+28.6%0.551%Search for SEC Filing on Google Icon
4/29/2024China Universal Asset Management Co. Ltd.11,935$0.18M0.0%+66.4%0.019%Search for SEC Filing on Google Icon
4/26/2024Pinnacle Associates Ltd.647,235$9.53M0.2%-5.9%1.035%Search for SEC Filing on Google Icon
4/18/2024Wasatch Advisors LP989,579$14.57M0.1%-23.7%1.582%Search for SEC Filing on Google Icon
4/18/2024Allspring Global Investments Holdings LLC12,701$0.19M0.0%-68.9%0.020%Search for SEC Filing on Google Icon
4/18/2024Diversified Trust Co13,630$0.20M0.0%+16.0%0.022%Search for SEC Filing on Google Icon
4/15/2024Sound Income Strategies LLC5,252$77K0.0%N/A0.008%Search for SEC Filing on Google Icon
4/5/2024Los Angeles Capital Management LLC53,113$0.78M0.0%-12.0%0.085%Search for SEC Filing on Google Icon
3/5/2024Wellington Management Group LLP238,123$2.29M0.0%-4.2%0.384%Search for SEC Filing on Google Icon
2/26/2024Perceptive Advisors LLC611,932$5.89M0.1%N/A0.987%Search for SEC Filing on Google Icon
2/16/2024Public Employees Retirement System of Ohio9,144$88K0.0%-24.7%0.015%Search for SEC Filing on Google Icon
2/15/2024Frazier Life Sciences Management L.P.2,401,704$23.10M1.2%+33.2%3.872%Search for SEC Filing on Google Icon
2/14/2024Pennant Investors LP43,800$0.42M0.1%N/A0.071%Search for SEC Filing on Google Icon
2/14/2024Wasatch Advisors LP1,297,574$12.48M0.1%-7.9%2.092%Search for SEC Filing on Google Icon
2/14/2024Bellevue Group AG9,953,313$95.75M1.5%+1.5%16.046%Search for SEC Filing on Google Icon
2/14/2024XML Financial LLC10,600$0.10M0.0%-27.4%0.017%Search for SEC Filing on Google Icon
2/13/2024Armistice Capital LLC4,572,000$43.98M0.6%-3.0%7.371%Search for SEC Filing on Google Icon
2/13/2024Campbell & CO Investment Adviser LLC93,005$0.90M0.1%N/A0.150%Search for SEC Filing on Google Icon
2/9/2024Trexquant Investment LP58,679$0.56M0.0%-64.8%0.095%Search for SEC Filing on Google Icon
2/9/2024Dynamic Technology Lab Private Ltd18,911$0.18M0.0%N/A0.030%Search for SEC Filing on Google Icon
2/8/2024Panagora Asset Management Inc.398,944$3.84M0.0%+5.4%0.643%Search for SEC Filing on Google Icon
2/8/2024Massachusetts Financial Services Co. MA165,107$1.59M0.0%-15.0%0.266%Search for SEC Filing on Google Icon
2/7/2024Principal Financial Group Inc.267,876$2.58M0.0%-2.8%0.432%Search for SEC Filing on Google Icon
2/7/2024Jump Financial LLC14,060$0.14M0.0%N/A0.023%Search for SEC Filing on Google Icon
2/7/2024BNP Paribas Financial Markets42,109$0.41M0.0%+144.5%0.068%Search for SEC Filing on Google Icon
2/6/2024Charles Schwab Investment Management Inc.833,500$8.02M0.0%+1.0%1.344%Search for SEC Filing on Google Icon
2/6/2024AJOVista LLC5,344$51K0.1%N/A0.009%Search for SEC Filing on Google Icon
2/6/2024Amalgamated Bank6,318$61K0.0%-8.9%0.010%Search for SEC Filing on Google Icon
2/6/2024Natixis Advisors L.P.30,892$0.30M0.0%N/A0.050%Search for SEC Filing on Google Icon
2/5/2024Russell Investments Group Ltd.15,342$0.15M0.0%-47.1%0.025%Search for SEC Filing on Google Icon
1/31/2024Federated Hermes Inc.803,375$7.73M0.0%-13.6%1.295%Search for SEC Filing on Google Icon
1/30/2024Cornercap Investment Counsel Inc.29,110$0.28M0.0%-17.6%0.047%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
MacroGenics logo
MacroGenics, Inc., a biopharmaceutical company, develops, manufactures, and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients with metastatic HER2-positive breast cancer who have received two or more prior anti-HER2 regimens. The company's pipeline of immuno-oncology product candidates includes MGC018, an antibody drug conjugate (ADC), which targets solid tumors expressing B7-H3; Enoblituzumab, a monoclonal antibody that targets B7-H3; and MGD024, an investigational bispecific CD123 × CD3 DART molecule to minimize cytokine-release syndrome for patients with hematologic malignancies. In addition, it develops Lorigerlimab, a monoclonal antibody that targets the immune checkpoints PD-1 and cytotoxic T-lymphocyte-associated protein 4; Tebotelimab, an investigational tetravalent DART molecule for PD-1 and lymphocyte-activation gene 3; Retifanlimab, a humanized monoclonal antibody targeting programmed death receptor-1; and IMGC936, an ADC that targets ADAM9, a cell surface protein over-expressed in various solid tumor types. Further, the company develops MGD014 and MGD020, a DART molecule to target the envelope protein of human immunodeficiency virus infected cells and CD3 on T cells; Teplizumab for the treatment of type 1 diabetes; and PRV-3279, a CD32B × CD79B DART molecule for the treatment of autoimmune indications. It has collaborations with Incyte Corporation; Zai Lab Limited; I-Mab Biopharma; and Janssen Biotech, Inc. The company was incorporated in 2000 and is headquartered in Rockville, Maryland.
Read More on MacroGenics

Today's Range

Now: $3.19
Low: $3.16
High: $3.33

50 Day Range

MA: $3.65
Low: $3.00
High: $4.46

52 Week Range

Now: $3.19
Low: $2.95
High: $21.88

Volume

404,966 shs

Average Volume

1,448,795 shs

Market Capitalization

$200.44 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.08

Who are the company insiders with the largest holdings of MacroGenics?

MacroGenics' top insider shareholders include:
  1. Target N V Biotech (Major Shareholder)
  2. Ezio Bonvini (SVP)
  3. Edward Hurwitz (Director)
  4. Jeffrey Stuart Peters (VP)
Learn More about top insider investors at MacroGenics.

Who are the major institutional investors of MacroGenics?

MacroGenics' top institutional investors include:
  1. Bellevue Group AG — 15.82%
  2. Wasatch Advisors LP — 4.04%
  3. State Street Corp — 2.27%
  4. Geode Capital Management LLC — 2.24%
  5. Vestal Point Capital LP — 1.32%
  6. Pinnacle Associates Ltd. — 1.10%
Learn More about top institutional investors of MacroGenics stock.

Which major investors are selling MacroGenics stock?

During the last quarter, MGNX stock was sold by these institutional investors:
  1. Ikarian Capital LLC
  2. State Street Corp
  3. Walleye Capital LLC
  4. Parallax Volatility Advisers L.P.
  5. MetLife Investment Management LLC
  6. Charles Schwab Investment Management Inc.
  7. Bellevue Group AG
  8. Geode Capital Management LLC
In the previous year, company insiders that have sold MacroGenics company stock include:
  1. Target N V Biotech (Major Shareholder)
  2. Ezio Bonvini (SVP)
Learn More investors selling MacroGenics stock.

Which major investors are buying MacroGenics stock?

During the previous quarter, MGNX stock was purchased by institutional investors including:
  1. Connor Clark & Lunn Investment Management Ltd.
  2. Jacobs Levy Equity Management Inc.
  3. FMR LLC
  4. GSA Capital Partners LLP
  5. Verition Fund Management LLC
  6. Wasatch Advisors LP
  7. BNP Paribas Financial Markets
  8. Pinnacle Associates Ltd.
Within the previous year, these company insiders have bought MacroGenics stock:
  1. Target N V Biotech (Major Shareholder)
  2. Ezio Bonvini (SVP)
Learn More investors buying MacroGenics stock.